<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2983306R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3565</journal-id>
<journal-id journal-id-type="nlm-ta">Epilepsia</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia</journal-id>
<journal-title-group>
<journal-title>Epilepsia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0013-9580</issn>
<issn pub-type="epub">1528-1167</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28035782</article-id>
<article-id pub-id-type="pmc">6582945</article-id>
<article-id pub-id-type="doi">10.1111/epi.13652</article-id>
<article-id pub-id-type="manuscript">NIHMS1035553</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>WONOEP appraisal: Biomarkers of epilepsy-associated comorbidities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ravizza</surname>
<given-names>Teresa</given-names>
</name>
<xref ref-type="aff" rid="A1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Onat</surname>
<given-names>Filiz Y.</given-names>
</name>
<xref ref-type="aff" rid="A2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brooks-Kayal</surname>
<given-names>Amy R.</given-names>
</name>
<xref ref-type="aff" rid="A3">‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Depaulis</surname>
<given-names>Antoine</given-names>
</name>
<xref ref-type="aff" rid="A4">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galanopoulou</surname>
<given-names>Aristea S.</given-names>
</name>
<xref ref-type="aff" rid="A5">¶</xref>
<xref ref-type="aff" rid="A6">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mazarati</surname>
<given-names>Andrey</given-names>
</name>
<xref ref-type="aff" rid="A7">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Numis</surname>
<given-names>Adam L.</given-names>
</name>
<xref ref-type="aff" rid="A7">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sankar</surname>
<given-names>Raman</given-names>
</name>
<xref ref-type="aff" rid="A7">**</xref>
<xref ref-type="aff" rid="A8">††</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Friedman</surname>
<given-names>Alon</given-names>
</name>
<xref ref-type="aff" rid="A9">‡‡</xref>
<xref ref-type="aff" rid="A10">§§</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>*</label>Department of Neuroscience, IRCCS—“Mario Negri” Institute for Pharmacological Research, Milano, Italy;</aff>
<aff id="A2"><label>†</label>Department of Medical Pharmacology, Epilepsy Research Center, School of Medicine Marmara University, Istanbul, Turkey;</aff>
<aff id="A3"><label>‡</label>Department of Pediatrics, Neurology and Pharmaceutical Sciences, Children’s Hospital Colorado, University of Colorado Schools of Medicine and Pharmacy, Aurora, Colorado, U.S.A.;</aff>
<aff id="A4"><label>§</label>Inserm U1216, Neuroscience Institute, Grenoble, France;</aff>
<aff id="A5"><label>¶</label>Laboratory of Developmental Neuroscience, Saul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York, U.S.A.;</aff>
<aff id="A6"><label>#</label>Montefiore/Einstein Comprehensive Epilepsy Center, Montefiore Medical Center, Bronx, New York, U.S.A.;</aff>
<aff id="A7"><label>**</label>Neurology Division, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.;</aff>
<aff id="A8"><label>††</label>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.;</aff>
<aff id="A9"><label>‡‡</label>Department of Physiology and Cell Biology, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel;</aff>
<aff id="A10"><label>§§</label>Department of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada</aff>
<author-notes>
<corresp id="CR1">Address correspondence to Teresa Ravizza, PhD, IRCCS—“Mario Negri” Institute for Pharmacological Reserach, Laboratory of Experimental Neurology, Department of Neuroscience, Via G La Masa 19, 20156 Milano, Italy. <email>teresa.ravizza@marionegri.it</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P38">Disclosures</p>
<p id="P39">None of the authors has any conflict of interest to disclose. The authors confirm that they have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>58</volume>
<issue>3</issue>
<fpage>331</fpage>
<lpage>342</lpage>
<!--elocation-id from pubmed: 10.1111/epi.13652-->
<abstract id="ABS1">
<title>SUMMARY</title>
<p id="P1">Neurologic and psychiatric comorbidities are common in patients with epilepsy. Diagnostic, predictive, and pharmacodynamic biomarkers of such comorbidities do not exist. They may share pathogenetic mechanisms with epileptogenesis/ictogenesis, and as such are an unmet clinical need. The objectives of the subgroup on biomarkers of comorbidities at the XIII Workshop on the Neurobiology of Epilepsy (WONOEP) were to present the state-of-the-art recent research findings in the field that highlighting potential biomarkers for comorbidities in epilepsy. We review recent progress in the field, including molecular, imaging, and genetic biomarkers of comorbidities as discussed during the WONOEP meeting on August 31–September 4, 2015, in Heybeliada Island (Istanbul, Turkey). We further highlight new directions and concepts from studies on comorbidities and potential new biomarkers for the prediction, diagnosis, and treatment of epilepsy-associated comorbidities. The activation of various molecular signaling pathways such as the “Janus Kinase/Signal Transducer and Activator of Transcription,” “mammalian Target of Rapamycin,” and oxidative stress have been shown to correlate with the presence and severity of subsequent cognitive abnormalities. Furthermore, dysfunction in serotonergic transmission, hyperactivity of the hypothalamic-pituitary-adrenocortical axis, the role of the inflammatory cytokines, and the contributions of genetic factors have all recently been regarded as relevant for understanding epilepsy-associated depression and cognitive deficits. Recent evidence supports the utility of imaging studies as potential biomarkers. The role of such biomarker may be far beyond the diagnosis of comorbidities, as accumulating clinical data indicate that comorbidities can predict epilepsy outcomes. Future research is required to reveal whether molecular changes in specific signaling pathways or advanced imaging techniques could be detected in the clinical settings and correlate with epilepsy-associated comorbidities. A reliable biomarker will allow a more accurate diagnosis and improved treatment of epilepsy-associated comorbidities.</p>
</abstract>
<kwd-group>
<kwd>Neurobehavioral comorbidities</kwd>
<kwd>Cognition</kwd>
<kwd>Depression</kwd>
<kwd>Imaging</kwd>
<kwd>Polymorphisms</kwd>
<kwd>Epilepsy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>